NeueHealth, Inc. (NEUE)
For informational purposes only. Not financial advice. Analysis by Sedat ANAK, Founder & Editor-in-Chief | AI-powered analysis. Data sourced from SEC filings and institutional-grade financial providers. Editorially reviewed. Not financial advice.
NeueHealth, Inc. (NEUE) trades at $6.75 with AI Score 42/100 (Grade C). NeueHealth, Inc. operates in the healthcare sector, providing services to health consumers, providers, and payors. Market cap: $60.94M, Sector: Healthcare.
Price live · AI analysis from Mar 17, 2026Analyst Coverage for NEUE: NEUE does not currently have published analyst price targets in our coverage universe. This is common for smaller-cap names with limited Wall Street coverage. In the absence of analyst consensus, our AI model evaluates NEUE against Healthcare peers across nine fundamental dimensions and assigns an underweight signal based on the underlying data.
NEUE: the 1 perspectives are evenly split.
How is this calculated? →NeueHealth, Inc. (NEUE) Healthcare & Pipeline Overview
NeueHealth, Inc. delivers healthcare services through its NeueCare and NeueSolutions segments, focusing on the ACA marketplace, Medicare, and Medicaid. Operating risk-bearing clinics and enabling providers in performance-based arrangements, NeueHealth aims to improve healthcare access and outcomes in a competitive landscape.
What Is the Investment Thesis for NEUE?
NeueHealth, Inc. presents a complex investment case. The company's focus on the ACA marketplace, Medicare, and Medicaid offers exposure to growing segments of the healthcare market. The NeueCare segment's integrated care model, with embedded services like pharmacy and lab, could drive efficiencies and improve patient outcomes. However, the company's negative P/E ratio of -0.62 and a negative profit margin of -10.7% indicate current challenges in achieving profitability. The company's market capitalization is $0.06 billion as of March 2026. Key catalysts include successful expansion of the NeueCare clinic network and increased adoption of the NeueSolutions platform by providers. Risks include regulatory changes in the healthcare industry and the company's ability to manage medical costs effectively.
Based on FMP financials and quantitative analysis
NEUE Key Highlights
- Market capitalization of $60.94M indicates a small-cap company with potential for growth but also higher volatility.
- P/E ratio of -0.62 reflects current unprofitability, requiring scrutiny of turnaround strategies.
- Gross margin of 24.2% suggests potential for improvement through cost management and operational efficiencies.
- Beta of 0.60 indicates lower volatility compared to the overall market, potentially appealing to risk-averse investors.
- The company rebranded from Bright Health Group, Inc. to NeueHealth, Inc. in January 2024, signaling a strategic shift.
Who Are NEUE's Competitors?
NEUE is benchmarked below against 8 industry peers on price, market cap, and our AI MoonshotScore.
| Company | Price | Change | Market Cap | AI Score |
|---|---|---|---|---|
| ACHL Achilles Therapeutics plc | $1.48 | +0.68% | $60.83M | 47 |
| AKYA Akoya Biosciences, Inc. | $1.29 | -5.15% | $64.44M | 50 |
| CCLD CareCloud, Inc. | $2.21 | -0.45% | $93.91M | 78 |
| HTBX Heat Biologics, Inc. | $2.38 | +0.42% | $61.07M | 48 |
| NAKA Kindly MD, Inc. | $4.19 | +8.67% | $72.99M | — |
| CWB State Street SPDR Bloomberg Convertible Securities ETF | $105.34 | +0.92% | $4.62B | 47 |
| TDV ProShares - S&P Technology Dividend Aristocrats ETF | $100.89 | +1.33% | $293.21M | 47 |
| DAUG FT Vest U.S. Equity Deep Buffer ETF - August | $46.97 | +0.26% | $363.40M | 47 |
AI Score by Stock Expert AI · Price data: FMP / Yahoo Finance
What Are NEUE's Key Strengths?
- Integrated care model with embedded services.
- Proprietary technology platform for value-based care.
- Established clinic network.
- Focus on growing segments of the healthcare market (ACA, Medicare, Medicaid).
What Are NEUE's Weaknesses?
- Negative P/E ratio and profit margin.
- Small market capitalization.
- Limited brand recognition.
- High level of competition in the healthcare industry.
What Could Drive NEUE Stock Higher?
- Expansion of the NeueCare clinic network into new geographic markets by Q4 2026.
- Increased adoption of the NeueSolutions platform by providers and medical groups.
- Strategic partnerships with other healthcare organizations to expand service offerings.
- Positive regulatory changes in the healthcare industry that support value-based care initiatives.
What Are the Key Risks for NEUE?
- Financial-distress signal — its Altman Z-Score of -7.77 sits in the distress zone (elevated bankruptcy risk).
- Weak fundamentals — a Piotroski F-Score of 3/9 flags soft profitability, leverage or efficiency.
- Regulatory changes in the healthcare industry that could negatively impact NeueHealth's business model.
- Increasing competition from established players and new entrants in the healthcare market.
- Rising medical costs that could erode profit margins.
- Economic downturn that could reduce demand for healthcare services.
What Are the Growth Opportunities for NEUE?
- Expansion of NeueCare Clinic Network: NeueHealth can expand its network of owned and affiliated clinics under the Centrum Health, AssociatesMD, and Premier Medical Associates brands. This expansion would allow the company to reach more patients and increase its market share in key geographic areas. The market for primary care services is estimated at $260 billion annually, providing a significant opportunity for growth. Timeline: Ongoing.
- Adoption of NeueSolutions Platform: The NeueSolutions segment can drive growth by increasing adoption of its platform among providers and medical groups. This platform enables providers to succeed in performance-based arrangements, which are becoming increasingly prevalent in the healthcare industry. The market for value-based care solutions is projected to reach $1 trillion by 2028. Timeline: Ongoing.
- Strategic Partnerships: NeueHealth can form strategic partnerships with other healthcare providers, payors, and technology companies to expand its reach and enhance its service offerings. These partnerships could provide access to new markets, technologies, and expertise. The market for healthcare partnerships is growing rapidly, with a focus on collaboration and innovation. Timeline: Ongoing.
- Technology Integration: Investing in technology to improve care coordination, patient engagement, and data analytics can drive growth and improve efficiency. This includes implementing telehealth solutions, developing mobile apps for patients, and using data analytics to identify and manage high-risk patients. The market for healthcare technology is projected to reach $390 billion by 2024. Timeline: Ongoing.
- Medicare Advantage Expansion: NeueHealth can expand its presence in the Medicare Advantage market, which is experiencing significant growth due to the aging population and increasing popularity of managed care plans. This expansion would allow the company to tap into a large and growing market segment. The Medicare Advantage market is projected to reach $590 billion by 2027. Timeline: Ongoing.
What Opportunities Does NEUE Have?
- Expansion of clinic network.
- Increased adoption of NeueSolutions platform.
- Strategic partnerships.
- Medicare Advantage expansion.
What Threats Does NEUE Face?
- Regulatory changes in the healthcare industry.
- Increasing competition.
- Rising medical costs.
- Economic downturn.
What Are NEUE's Competitive Advantages?
- Integrated Care Model: NeueHealth's integrated care model, with embedded services like pharmacy and lab, provides a competitive advantage by improving care coordination and patient convenience.
- Proprietary Technology Platform: The NeueSolutions platform provides a competitive advantage by enabling providers to succeed in performance-based arrangements.
- Established Clinic Network: The company's network of owned and affiliated clinics provides a strong foundation for growth and expansion.
What Does NEUE Do?
NeueHealth, Inc., established in 2015 and headquartered in Doral, Florida, is a healthcare company focused on providing a range of services to health consumers, providers, and payors in the United States. Formerly known as Bright Health Group, Inc., the company rebranded to NeueHealth, Inc. in January 2024, signaling a strategic shift in its business approach. NeueHealth operates through two primary segments: NeueCare and NeueSolutions. The NeueCare segment delivers healthcare services to individuals covered by the ACA marketplace, Medicare, and Medicaid through a network of owned and affiliated clinics. These clinics operate under the brand names Centrum Health, AssociatesMD, and Premier Medical Associates. The segment offers an integrated system care solution, including embedded pharmacy, laboratory, radiology, and population health focused specialty services. It also provides chronic care management, transitions of care, and referral management services. The NeueSolutions segment focuses on enabling providers and medical groups to succeed in performance-based arrangements. This segment also participates in programs designed to improve healthcare access for Medicare beneficiaries. NeueHealth's business model is centered around providing comprehensive and coordinated care, leveraging technology and data analytics to improve patient outcomes and reduce costs. The company aims to create a more efficient and effective healthcare system by aligning incentives and empowering providers to deliver high-quality care.
What Products and Services Does NEUE Offer?
- Provides healthcare services to health consumers, providers, and payors in the United States.
- Operates through NeueCare and NeueSolutions segments.
- Delivers healthcare services to ACA marketplace, Medicare, and Medicaid enrollees.
- Operates risk-bearing clinics under the Centrum Health, AssociatesMD, and Premier Medical Associates brands.
- Offers integrated system care solutions, including pharmacy, laboratory, and radiology services.
- Provides chronic care management, transitions of care, and referral management services.
- Enables providers and medical groups to succeed in performance-based arrangements.
- Participates in programs designed to improve healthcare access for Medicare beneficiaries.
How Does NEUE Make Money?
- Generates revenue through providing healthcare services to patients in its owned and affiliated clinics.
- Earns fees from providers and medical groups for using the NeueSolutions platform.
- Participates in risk-sharing arrangements with payors, where it shares in the cost savings generated by its care management programs.
What Industry Does NEUE Operate In?
NeueHealth operates in the dynamic and highly regulated healthcare industry. The industry is characterized by increasing demand for value-based care, driven by rising healthcare costs and a growing emphasis on patient outcomes. The competitive landscape includes established players such as ACHL, AKYA, CCLD, HTBX, and NAKA, as well as new entrants focused on innovative care delivery models. NeueHealth's focus on integrated care and performance-based arrangements aligns with industry trends, but the company faces challenges in scaling its operations and achieving profitability in a competitive market.
Who Are NEUE's Key Customers?
- Health consumers enrolled in ACA marketplace, Medicare, and Medicaid plans.
- Providers and medical groups seeking to improve their performance in value-based care arrangements.
- Payors looking to partner with organizations that can help them manage costs and improve patient outcomes.
F-Score 3/9Financial Health
NeueHealth, Inc.'s Piotroski F-Score is 3/9, a 9-point checklist of profitability, leverage and efficiency — flagging fundamental weakness worth scrutiny. Its Altman Z-Score of -7.77 places it in the distress zone, a signal of elevated financial risk.
ROE 6%Key Financial Metrics
Return on equity for NeueHealth, Inc. stands at 5.6%, a gauge of how efficiently it converts shareholder capital into profit. Return on assets is -3.3%, showing how much profit it generates from its asset base. Its free cash flow yield is -84.9%, a gauge of the cash the business throws off relative to its market value. A current ratio of 0.70 means current liabilities exceed short-term assets, a liquidity point worth watching. Its earnings yield is -41.5%, the inverse of the P/E and a quick read on earnings relative to price.
NeueHealth, Inc. (NEUE) Valuation Context
Valued at $60.94M, NEUE is classified as a micro-cap stock. Relative to its peer group, NEUE's quantitative score of 42/100 is below the peer average of 56/100.
FY2026 estForward Outlook
Wall Street analysts project NeueHealth, Inc. revenue of about $900.1M for fiscal 2026, with EPS near $0.77.
Net sellingInsider Activity
The most recent 12 insider filings for NeueHealth, Inc. break down as 12 sales and 0 purchases. On net that is roughly 1.3M shares disposed (about $0), a signal worth weighing alongside the fundamentals.
NEUE Financials
Fundamental Snapshot
Based on FMP financials and quantitative analysis · FY 2024
Bull Case vs Bear Case
Bull Case
- Recent insider buying suggests confidence in NeueHealth's future, indicating that leadership believes in the company's growth potential.
- Community sentiment has shifted positively, with discussions highlighting the company's innovative healthcare solutions and their relevance in today's market.
- Strategic partnerships announced recently are expected to enhance service offerings and expand market reach, which could drive future revenue growth.
- Positive news coverage has focused on NeueHealth's commitment to improving patient outcomes, resonating well with socially conscious investors.
Bear Case
- Concerns about regulatory changes in the healthcare sector have led to increased uncertainty among investors, dampening sentiment.
- Recent earnings reports have shown mixed results, causing some community members to express skepticism about the company's financial health moving forward.
- Market perception is clouded by broader economic challenges, which may impact healthcare spending and affect NeueHealth's growth trajectory.
- Some analysts have raised questions about the scalability of NeueHealth's business model, leading to cautious sentiment in trading circles.
AI-generated arguments based on insider flow, news sentiment and technicals — not financial advice · March 2026
NEUE Latest News
-
Earnings Scheduled For May 8, 2025
benzinga · May 8, 2025
NEUE Analyst Consensus
Consensus Rating
Aggregated Buy/Hold/Sell recommendations from Benzinga, Yahoo Finance, and Finnhub for NEUE.
Price Targets
Wall Street price target analysis for NEUE.
NEUE MoonshotScore
What does this score mean?
The MoonshotScore rates NEUE's growth potential on a scale of 0-100 across multiple factors including innovation, market disruption, financial health, and momentum.
Leadership: George Lawrence Mikan III
Chief Executive Officer
George Lawrence Mikan III serves as the Chief Executive Officer of NeueHealth, Inc. His background includes extensive experience in the healthcare industry, with a focus on managed care and healthcare delivery. Prior to joining NeueHealth, Mikan held leadership positions at various healthcare organizations, where he was responsible for strategic planning, operations, and financial management. He has a proven track record of driving growth and improving operational efficiency. Mikan's expertise in value-based care and population health management is critical to NeueHealth's success.
Track Record: Since assuming the role of CEO, George Lawrence Mikan III has overseen the rebranding of the company from Bright Health Group, Inc. to NeueHealth, Inc., signaling a strategic shift in the company's focus. He is focused on improving the company's financial performance and expanding its market presence. Mikan is also leading efforts to enhance the company's technology platform and improve care coordination.
NeueHealth, Inc. Healthcare Stock: Key Questions Answered
What does NeueHealth, Inc. do?
NeueHealth, Inc. operates as a healthcare services company, providing solutions for health consumers, providers, and payors. Through its NeueCare segment, NeueHealth delivers healthcare services via owned and affiliated clinics, targeting the ACA marketplace, Medicare, and Medicaid populations. The NeueSolutions segment enables providers and medical groups to succeed in performance-based arrangements. NeueHealth aims to improve healthcare access and outcomes by offering integrated care solutions and leveraging technology to enhance care coordination and efficiency.
What do analysts say about NEUE stock?
Analyst coverage of NeueHealth, Inc. (NEUE) is currently limited, reflecting its small-cap status and recent strategic shift. Key valuation metrics, such as the negative P/E ratio, suggest caution. Growth considerations center on the company's ability to scale its NeueCare clinic network, expand the adoption of its NeueSolutions platform, and manage medical costs effectively. Investors should closely monitor the company's financial performance and progress in achieving profitability.
What are the main risks for NEUE?
NeueHealth, Inc. faces several key risks, including regulatory changes in the healthcare industry, increasing competition from established players and new entrants, and rising medical costs. The company's reliance on the ACA marketplace, Medicare, and Medicaid makes it vulnerable to policy changes and reimbursement pressures. Additionally, NeueHealth's ability to manage medical costs effectively is critical to its profitability and long-term success. The company's small market capitalization also exposes it to higher volatility and liquidity risks.
What are the key factors to evaluate for NEUE?
NeueHealth, Inc. (NEUE) holds an AI score of 42/100 (low). Not financial advice.
How frequently does NEUE data refresh on this page?
NEUE prices update in real time during U.S. market hours. Fundamentals refresh after quarterly filings; analyst ratings and AI insights update daily; news is aggregated continuously.
What has driven NEUE's recent stock price performance?
NeueHealth, Inc. (NEUE) moves on earnings results, analyst revisions, sector rotation, and market sentiment. Notable catalyst: Integrated care model with embedded services. See the News tab for the latest drivers. Past performance does not predict future results.
Should investors consider NEUE overvalued or undervalued right now?
Valuing NeueHealth, Inc. (NEUE) requires multiple metrics. Compare P/E, P/S, and EV/EBITDA against sector peers for a full view.
What research should beginners do before buying NEUE?
Before investing in NeueHealth, Inc. (NEUE), research these four areas: (1) the company's revenue model and competitive position (see Company Overview), (2) financial health through revenue growth, margins, and cash flow (see MoonshotScore), (3) what Wall Street analysts recommend and their price targets (see Analyst tab), and (4) specific risk factors that could impact the stock (see Risk Factors section).
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Official Resources
Data provided for informational purposes only.
- Financial data may be outdated.
- AI analysis pending.